Methodological considerations for designing and conducting open-label placebo trials

Area of Science:

• Pain research
• Psychoneurobiology
• Clinical trials

Background:

• Traditionally, placebos involved deception, but open-label placebos (OLPs) demonstrate therapeutic effects without it.
• OLPs involve openly and transparently administering inert treatments, enabling patients to knowingly receive them for benefits like pain relief.
• Growing OLP research necessitates addressing methodological challenges in unblinded experimental and clinical designs.

Purpose of the Study:

• To outline key methodological considerations for designing and conducting OLP studies.
• To provide guidance on control group selection, blinding strategies, and reporting standards for OLP trials.
• To integrate patient perspectives for a more patient-centered approach to OLP research.

Main Methods:

• Review of methodological considerations for OLP study design.
• Guidance on control group selection and blinding strategies.
• Integration of patient advisory board insights on OLP feasibility and acceptability.

Main Results:

• Identified challenges in OLP trials include defining control groups, implementing blinding, and explaining treatment rationale.
• Emphasized the need for methodological rigor to understand OLP psychoneurobiological mechanisms and clinical relevance.
• Highlighted the importance of patient perspectives for enhancing OLP research quality and clinical translation.

Conclusions:

• Addressing methodological rigor and patient-centeredness is crucial for advancing OLP research in pain and beyond.
• Methodological guidance combined with patient insights can improve the quality and clinical relevance of OLP studies.
• Aligning OLP study designs with patient needs fosters a more meaningful and effective approach to pain management research.